Joel Greenblatt · Magic Formula: high return on capital at a cheap EV/EBIT
Is Halozyme Therapeutics, Inc. (HALO) a Joel Greenblatt Stock?
Low Magic Formula score: expensive, low ROIC, or both.
42/100
Mixed
1/5 criteria passed
Joel Greenblatt's Criteria, Applied to HALO
EBIT/EV yield ≥ 10%
key8.2%
ROIC ≥ 25%
key23.6%
EV/EBIT ≤ 12
12.2x
Gross margin ≥ 30%
76.9%
How HALO Scores on Other Strategies
Live Financial Snapshot
Market cap
$14.89B
P/E (TTM)
23.3x
ROIC (TTM)
23.65%
Gross margin
76.93%
Other Joel Greenblatt fit reports
Frequently Asked Questions
What is HALO's Joel Greenblatt fit score?
HALO scores 42/100 on our Joel Greenblatt fit engine. Low Magic Formula score: expensive, low ROIC, or both.
Does Joel Greenblatt actually own HALO?
Our score is computed from financial fundamentals against Joel Greenblatt's published criteria. We don't claim that Joel Greenblatt personally owns or recommends HALO.
How often is this score updated?
HALO's Joel Greenblatt fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Joel Greenblatt personally owns or recommends HALO.
